GMV leads a Consortium that will create a federated network to speed up the use of AI in healthcare systems

GMV, along with 15 other entities participating as a consortium, will be responsible for creating a federated network that uses artificial intelligence to accelerate health care research in Spain. The project, known as TARTAGLIA, will take place under the R&D Missions in Artificial Intelligence program, which is part of the Digital Spain 2025 agenda and the National Artificial Intelligence Strategy. The project will be funded by the European Union using Next Generation EU funds, with a budget of over €7.5 million.

Clinical data associated with individuals is both critical and sensitive in nature, and for reasons of security and privacy, use of such data to create artificial intelligence models is highly restricted by law and by government policy. Application of new technologies to solve this problem, and the ability to experiment with governance of a secure federated network, are key factors that will allow all of Spain’s regions and government health institutions to contribute to the data banks, and also to benefit from them.

GMV’s work on the project will consist of applying advanced cryptographic methods to ensure that patient data remains encrypted while all of the necessary calculations are being performed, to create a balance between privacy and the ability to make use of that data, without exposing it and without the need to transfer it away from the organizations involved.

This work will enhance training of the mathematical models and support decision-making, while also contributing to the advancement of personalized, precision medicine. In turn, this will improve the treatment received by patients and accelerate the pace of clinical trials, among other benefits.

In addition to a line of research focused on a federated learning configuration, the TARTAGLIA project will use AI to address other research challenges, such as the use of ultrasound for diagnosis and applications for AI in four clinical areas: Alzheimer’s disease, prostate cancer, diabetes, and complex chronic disease.

Read the press release here.

*TARTAGLIA is part of the R&D Missions in Artificial Intelligence program of the Spain Digital 2025 agenda and the National Artificial Intelligence Strategy, and is funded by the European Union through NextGenerationEU funds. The actions carried out will be reported to the Ministry of Economic Affairs and Digital Transformation (file no. MIA.2021.M02.0005), corresponding to the funds of the Recovery, Resilience and Transformation Plan, co-funded by the European Union, NextGeneration.